side effects of stopping glp 1 Taking GLP‑1 Without Diabetes in 2026: What Real People Notice After 3, 6 and 12 Months GLP-1 Survey: 37.5% of People

Although limited by small sample size and lack of controls, this study represents the first human validation of the technical feasibility and clinical potential of intra-articular laser therapy

Your risk for getting low blood sugar may be higher if you use Ozempic with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin

In 2025, the European Medicines Agency concluded that NAION should be listed as a very rare side effect of semaglutide medications, including Ozempic, Wegovy, and Rybelsus, after reviewing clinical studies, adverse event reports, and post-market safety data

Ozempic is the brand name for semaglutide, a medication that belongs to a class of drugs known as GLP-1 receptor agonists